Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs)

Author(s): Tom Hsun-Wei Huang, Basil D. Roufogalis

Journal Name: Current Molecular Pharmacology

Volume 5 , Issue 2 , 2012

Become EABM
Become Reviewer
Call for Editor


Cardiometabolic syndrome is a mixture of interrelated risk factors predisposing individuals to elevated risk of atherosclerotic cardiovascular disease and type 2 diabetes mellitus. Nuclear receptors, specifically peroxisome proliferator-activated receptors (PPARs), were identified to play a pivotal role in the regulation of metabolic homeostasis. However, with rosiglitazone currently under intense scrutiny great concerns have arisen regarding the safety of the thiazolidinedione PPAR-γ agonist family as a whole. This review discusses the current concern with PPAR-γ agonists by exploring if PPARs can still be considered worth pursuing as a viable target for cardiovascular diseases. We examine current research focusing on identifying ligands that are dual and pan-PPAR agonists, selective PPAR-γ modulators, PPAR-β/δ agonists and that are of natural origin.

Keywords: Cardiometabolic syndrome, diabetes mellitus, herbal and traditional natural medicines, peroxisome proliferator-activated receptor-γ

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 20 May, 2012
Page: [241 - 247]
Pages: 7
DOI: 10.2174/1874467211205020241
Price: $65

Article Metrics

PDF: 13